Prof. Marco D'Amelio

Neurologo Altro

Palermo 1 indirizzo

4 recensioni
Prenota una visita
Prenota una visita
Tempo medio di risposta:
Logo
Prof. Marco D'Amelio

Via Gaetano la Loggia 1, Palermo 90144

**IMPORTANTE**
Dopo la prenotazione dello slot, è obbligatorio per finalizzare l'appuntamento contattare il Dottore al numero +39 338 281 0566 (si preferiscono chiamate).

14/11/2024

Comunicazioni importanti

Logo
Prof. Marco D'Amelio

Via Gaetano la Loggia 1, Palermo 90144

**IMPORTANTE**
Dopo la prenotazione dello slot, è obbligatorio per finalizzare l'appuntamento contattare il Dottore al numero +39 338 281 0566 (si preferiscono chiamate).

14/11/2024

Esperienze

Marco D'amelio-0
Laurea in Medicina e Chirurgia (1991), specialista in Neurologia (1995)
Prof. Associato di Neurologia presso Università degli Studi di Palermo

Referente aziendale del centro Malattia di Parkinson e Parkinsonismi Azienda Policlinico Universitario P. Giaccone

Responsabile dell’ambulatorio Malattia di Parkinson e disordini del movimento. Attività: Identificazione pazienti da sottoporre a trattamento di neurochirurgia funzionale cerebrale e follow-up pazienti sottoposti a Deep Brain Stimulation; identificazione pazienti da sottoporre a trattamento infusivo con duodopa, partecipazione a procedura implementazione con duodopa, follow-up pazienti in trattamento.

Responsabile ambulatorio di Neurologia terapia con MRgFUS (Unità di terapia con ultrasuoni focalizzati guidati da RMN)
Valutazione neurologica clinica per candidabilità a trattamento di neurochirurgia funzionale cerebrale e follow-up pazienti con tremore essenziale e Malattia di Parkinson Tremor Dominant Parkinson’s sottoposti a talamotomia con ultrasuoni focalizzati
Altro

Su di me

Laurea in Medicina e Chirurgia (1991), specialista in Neurologia (1995)
Prof. Associato di Neurologia presso Università degli Studi di Palermo

Referente aziendale del centro Malattia di Parkinson e Parkinsonismi Azienda Policlinico Universitario P. Giaccone

Responsabile dell’ambulatorio Malattia di Parkinson e disordini del movimento. Attività: Identificazione pazienti da sottoporre a trattamento di neurochirurgia funzionale cerebrale e follow-up pazienti sottoposti a Deep Brain Stimulation; identificazione pazienti da sottoporre a trattamento infusivo con duodopa, partecipazione a procedura implementazione con duodopa, follow-up pazienti in trattamento.

Responsabile ambulatorio di Neurologia terapia con MRgFUS (Unità di terapia con ultrasuoni focalizzati guidati da RMN)
Valutazione neurologica clinica per candidabilità a trattamento di neurochirurgia funzionale cerebrale e follow-up pazienti con tremore essenziale e Malattia di Parkinson Tremor Dominant Parkinson’s sottoposti a talamotomia con ultrasuoni focalizzati
Aree di competenza principali:
  • Neurologia

Esperienze

Doctor
Marco D'Amelio

neurologo

4 recensioni
Patologie trattate
Mostra dettagli
Competenze linguistiche
  • Inglese
Tirocini
  • "Postodoctoral Research Scientist” presso il G. Sergievsky Center (Columbia University, New York, NY, USA)
Pubblicazioni
  • 82. Influence of ventral tegmental area (A10 region) on flight behaviour elicited by hypothalamic stimulation in the cat. Brain Res. 1993 May 7;610(2):242-7.
  • 81. Monosymptomatic presentation of type I Arnold-Chiari malformation: report of two cases. Ital J Neurol Sci. 1994 Feb;15(1):57-60.
  • 80. Transient topographical amnesia and cingulate cortex damage: a case report. Neuropsychologia. 1996 Apr;34(4):321-6.
  • 79. The IHS classification criteria for migraine headaches in adolescents need minor modifications. Headache. 1996;36:362-6.
  • 78. Incidence and risk factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology. 2001;56:519-25.
  • 77. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand. 2004;110:23-6.
  • 76. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology. 2004; 62:2010-4.
  • 75. Tumor diagnosis preceding Parkinson's disease: a case-control study. Mov Disord. 2004;19:807-11.
  • 74. Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study. Neuroepidemiology. 2004;23:306-9.
  • 73. Levetiracetam in the treatment of vascular chorea: a case report. Eur J Clin Pharmacol. 2005;60:835-6.
  • 72. Prevalence and risk factors of post-polio syndrome in a cohort of polio survivors. J Neurol Sci. 2005;236:31-5.
  • 71. Long-term survival of Parkinson's disease: a population-based study. J Neurol. 2006;253:33-7.
  • 70. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol. 2005;58:803-7.
  • 69. Mortality in the first 30 days following incident acute symptomatic seizures. Epilepsia. 2005;46 Suppl 11:43-5.
  • 68. Search for genetic factors associated with susceptibility to multiple sclerosis. Ann N Y Acad Sci. 2006;1067:264-9.
  • 67. Age at menopause predicts age at onset of Parkinson's disease. Mov Disord. 2006;21:2211-4.
  • 66. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy. Neuroepidemiology. 2007;28:28-32.
  • 65. Implications for estrogens in Parkinson's disease: an epidemiological approach. Ann N Y Acad Sci. 2006;1089:373-82.
  • 64. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. Parkinsonism Relat Disord. 2007;13:528-31.
  • 63. Dropped head as an unusual presenting sign of myasthenia gravis. Neurol Sci. 2007;28:104-6.
  • 62. Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects. Exp Brain Res. 2008;184:521-8.
  • 61. Height as a potential indicator of early life events predicting Parkinson's disease: a case-control study. Mov Disord. 2007;22:2263-7.
  • 60. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease. Mov Disord. 2008;23:21-7.
  • 59. Mortality in multiple sclerosis: a review. Eur J Neurol. 2008;15:123-7.
  • 58. Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily. Parkinsonism Relat Disord. 2008;14:572-5.
  • 57. Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early-onset Parkinson's disease. Parkinsonism Relat Disord. 2008;14:509-12.
  • 56. Body mass index does not change before Parkinson's disease onset. Eur J Neurol. 2008;15:965-8.
  • 55. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Mult Scler. 2009;15:204-11.
  • 54. Predictors of caregiver burden in partners of patients with Parkinson's disease. Neurol Sci. 2009;30:171-4.
  • 53. Parkinson's disease and cancer: insights for pathogenesis from epidemiology . Ann N Y Acad Sci. 2009;1155:324-34.
  • 52. Diabetes preceding Parkinson's disease onset. A case-control study. Parkinsonism Relat Disord. 2009;15:660-4.
  • 51. Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci. 2009;30:361-4.
  • 50. Frequency and determinants for hemorrhagic transformation of cerebral infarction. Neuroepidemiology. 2009;33:261-5.
  • 49. Progressive necrotic encephalopathy following tacrolimus therapy for liver transplantation. Neurol Sci. 2009;30:527-9.
  • 48. Leprosy: report of a case with severe peripheral neuropathy. Neurol Sci. 2010;31:75-7.
  • 47. Multiple sclerosis survival: a population based study in Sicily. Eur J Neurol. 2010; 17:391-7.
  • 46. MRI abnormalities following repeated and incoming seizures. Seizure. 2011;20:90-2.
  • 45. Prevalence of red ear syndrome in juvenile primary headaches. Cephalalgia. 2011;31:597-602.
  • 44. Protective role of heat shock proteins in Parkinson's disease. Neurodegener Dis. 2011;8:155-68.
  • 43. Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura. Neurol Sci. 2011;32:469-72.
  • 42. A population-based survey of cognitive performance in a Sicilian elderly community. Neuroepidemiology. 2011;36(3):169-76.
  • 41. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovasc Dis. 2011;32:234-8.
  • 40. Dentatorubral-pallidoluysian atrophy: haplotype of Asian origin in 2 Italian families. Mov Disord. 2012;27:460-1.
  • 39. Incidence of amyotrophic lateral sclerosis in Sicily: A population based study. Amyotroph Lateral Scler. 2012;13:284-7.
  • 38. Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease? J Alzheimers Dis. 2012;31:177-82.
  • 37. Sleep quality in caregivers of patients with Alzheimer's disease and Parkinson's disease and its relationship to quality of life. Int Psychogeriatr. 2012 Nov;24(11):1827-35. Erratum in: Int Psychogeriatr. 2013;25:1211.
  • 36. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke. J Stroke Cerebrovasc Dis. 2014; 23: 649-54.
  • 35. Neurofunctional correlates of attention rehabilitation in Parkinson's disease: an explorative study. Neurol Sci. 2014;35:1173-80.
  • 34. Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease. Neurol Sci. 2014;35:1615-7.
  • 33. Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study. Mov Disord. 2014;29:1064-9.
  • 32. Migraine and cranial autonomic symptoms in children and adolescents: a clinical study. J Child Neurol. 2015;30:182-6.
  • 31. Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology. 2014;83:215-20
  • 30. Migraine in a pediatric population: a clinical study in children younger than 7 years of age Dev Med Child Neurol. 2015;57:585-8.
  • 29. Juvenile migraine and allodynia: results of a retrospective study. Headache. 2015;55:413-8.
  • 28. Pisa syndrome after rasagiline therapy in a patient with Parkinson's disease. Neurol Sci. 2015;36:2305.
  • 27. In patient's with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms.Clin Auton Res. 2015;25:301-7.
  • 26. Red Ear Syndrome. Curr Pain Headache Rep. 2016;20(3):19.
  • 25. Effects of more-affected versus less-affected motor cortex tDCS in Parkinson’s disease Front Hum Neurosci. 2017 Jun 12;11:309
  • 24. Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study Multiple Sclerosis and Demyelinating Disorders (2017) 2:12
  • 23. Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study. BMC Neurol. 2017;17:155.
  • 22. Frequency and determinants of hemorrhagic transformation of Posterior cerebral stroke BMC Res Notes. 2017;10:592.
  • 21. Factors influencing psychological well-being in patients with Parkinson's disease. PLoS One. 2017 Dec 15;12(12):e018968
  • 20. Preliminary experience with a transcranial magnetic resonance-guided focused ultrasound surgery system integrated with a 1.5-T MRI unit in a series of patients with essential tremor and Parkinson's disease. Neurosurg Focus. 2018 Feb;44(2):E7
  • 19. Urological dysfunctions in patients with Parkinson's disease: clues from clinical and non-invasive urological assessment. BMC Neurol. 2018;18:148
  • 18. The Mystery of "Red Ear Syndrome": Sign or Syndrome. Headache 2019;59:624-625.
  • 17. Effects of transcranial random noise stimulation combined with Graded Repetitive Arm Supplementary Program (GRASP) on motor rehabilitation of the upper limb in sub-acute ischemic stroke patients: a randomized pilot study. J Neural Transm (Vienna). 2019 Dec;126(12):1701-1706.
  • 16. Impaired circadian heart rate variability in Parkinson’s disease: a time-domain analysis in ambulatory setting BMC Neurol. 2020 Apr 23;20(1):152.
  • 15. DCTN1 Mutation analysis in italian patients with PSP; MSA and DLB Neurobiology of Aging, 2020
  • 14. Intraoperative imaging findings in transcranial MR imaging-guided focused ultrasound treatment at 1.5T may accurately detect typical lesional findings correlated with sonication parameters Eur Radiol, 2020
  • 13. Transcranial magnetic resonance-guided focused ultrasound thalamotomy as a safe treatment option in multiple sclerosis patients with essential tremor. Neurol Sci. 2021 Mar;42(3):1139-1143.
  • 12. Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound Treatment at 1.5 T: A Retrospective Study on Treatment- and Patient-Related Parameters Obtained From 52 Procedures Front. Phys. 7:223., 2020 doi: 10.3389/fphy
  • 11. Preoperative imaging findings in patients undergoing transcranial magnetic resonance imaging-guided focused ultrasound thalamotomy. Sci Rep. 2021 Jan 28;11(1):2524.
  • 10. Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection. Neurol Int. 2021 Dec 6;13(4):695-700.
  • 9. Cognitive and motor effects of Kinect-based games training in people with and without Parkinson disease: A preliminary study. Physiother Res Int. 2020 Jan;25(1):e1807.
  • 8. Assessment of the Kinematic Adaptations in Parkinson's Disease Using the Gait Profile Score: Influences of Trunk Posture, a Pilot Study. Brain Sci. 2021 Dec 3;11(12):1605.
  • 7. Vitamin D and Parkinson's Disease. Nutrients. 2022 Mar 14;14(6):1220.
  • 6. ANXA1 mutation analysis in Italian patients with early onset PD. Neurobiol Aging. 2023 May;125:123-124.
  • 5. Exergaming in the treatment of gait, balance, and quality of life in Parkinson's disease: Overview of systematic reviews. Physiother Res Int. 2023 Apr 6:e2002.
  • 4. COVID-19 and neurological disorders: what might connect Parkinson's disease to SARS-CoV-2 infection. Front Neurol. 2023 May 18;14:1172416.
  • 3. Real-world use of Safinamide in motor fluctuating Parkinson's disease patients in Italy. Neurol Sci. 2023 Sep 9.
  • 2. Duration, numerosity and length processing in healthy ageing and Parkinson's disease. Eur J Ageing. 2024 Apr 24;21(1):14.
  • 1. Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience. Neurol Int. 2024 Jul 10;16(4):761-775.
Mostra dettagli
Formazione
  • Università degli Studi di Palermo
Certificati
Premi e riconoscimenti
  • 2000 - Epilepsy Foundation of America, Progetto “Epilepsy in Cancer patients: a population-based study using the SEER-Medicare database”
  • 1998 - CNR per lo studio “Prognostic factors in Status Epilepticus. A retrospective study (1965-1985) in Rochester, Minnesota (U.S.A.)”
Prenota una visita

Indirizzo

Clinica Neurologica
Via Gaetano la Loggia 1, Palermo
Vedi mappa

Pazienti senza assicurazione sanitaria

Presso questo indirizzo visito: adulti
338 281... Mostra numero

Telefono

Clinica Neurologica

Risparmia tempo! Prenota online:

Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.

Puoi anche inviare un messaggio

Tempo medio di risposta:

Prestazioni disponibili

Clinica Neurologica

Hai dubbi o domande?

Tempo medio di risposta:

Prestazioni suggerite

Prima visita neurologica • 150 €

Altre prestazioni

Visita neurologica di controllo • 120 €
Invia messaggio
Prenota una visita

Prestazioni e prezzi

Prima visita neurologica

150 €
Dettagli

Visita neurologica di controllo

120 €
Dettagli

Come funzionano i prezzi?

4 recensioni

Aggiungi una recensione

Punteggio generale

Tutte le recensioni contano e non possono essere rimosse o modificate dai dottori a proprio piacimento. Scopri come funziona il processo di moderazione delle recensioni.

Ordina recensioni per

S
Appuntamento verificato
• Presso: Clinica Neurologica • visita neurologica di controllo

Consiglio il Dottore senza esitazione. Professionale, emapatico, preparazione elevata, onesto e chiaro nel guidare il paziente e i suoi famigliari.

N
Appuntamento verificato
• Presso: Clinica Neurologica • prima visita neurologica

Mi ha ascoltato con attenzione e mi ha dedicato molto tempo.

M
Appuntamento verificato
• Presso: Clinica Neurologica • prima visita neurologica

La visita è andata bene il professore viene incontro ai problemi del paziente e ispira fiducia e tranquillità

B
Appuntamento verificato
• Presso: Clinica Neurologica • prima visita neurologica

Ottima persona e professionista competente e chiaro

Si è verificato un errore, riprova
Ricerche correlate
Città vicino Palermo
Principali patologie trattate

Informazioni sul prezzo

Clinica Neurologica

I prezzi di alcune prestazioni possono variare a seconda del singolo caso. Dopo aver effettuato una prenotazione, puoi chiedermi il prezzo di una specifica prestazione inviandomi un messaggio privato. Prenota ora la data più adatta alle tue esigenze.

Hai dubbi o domande?

Tempo medio di risposta:

La prenotazione e la cancellazione della visita sono servizi gratuiti

Hai dubbi o domande?

Tempo medio di risposta:

E' necessario il pagamento della tua visita

Il dottore con cui hai prenotato richiede di effettuare il pagamento. Per riprogrammare il tuo appuntamento, procedi con il pagamento oppure contatta direttamente il dottore.
Le mie visite Paga